ScholarIQanswers from OpenAlex
UCB Pharma (Belgium)
InstitutionResearch output, impact & collaborations
UCB Pharma (Belgium) is a institution indexed in ScholarIQ from OpenAlex.
What is known about UCB Pharma (Belgium)?
ScholarIQrecord summary
UCB Pharma (Belgium) is a research organisation in Brussels, BE. OpenAlex records 3,889 works and 263,453 citations for it. 1,063 researchers list it as their most recent affiliation.
How many works does UCB Pharma (Belgium) have?
ScholarIQindexed works
UCB Pharma (Belgium) has 3,889 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does UCB Pharma (Belgium) have?
ScholarIQcitation count
UCB Pharma (Belgium) has 263,453 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at UCB Pharma (Belgium)?
ScholarIQresearcher count
UCB Pharma (Belgium) has 1,063 researchers in the ScholarIQ index.
What is the average h-index at UCB Pharma (Belgium)?
ScholarIQavg h-index
UCB Pharma (Belgium) has an average h-index of 47.5 in OpenAlex.
What is the ROR of UCB Pharma (Belgium)?
ScholarIQror
The ROR for UCB Pharma (Belgium) is on the source record.
What is the OpenAlex record for UCB Pharma (Belgium)?
ScholarIQopenalex
The OpenAlex for UCB Pharma (Belgium) is on the source record.
Who are the most-cited researchers behind UCB Pharma (Belgium)?
ScholarIQtop researchers by citations
What are the most-cited papers on UCB Pharma (Belgium)?
ScholarIQmost cited works
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Rahul S. Desikan, Florent Ségonne, Bruce Fischl, Brian T. Quinn, Bradford C. Dickerson, Deborah Blacker, Randy L. Buckner, Anders M. Dale, R. P. Maguire, Bradley T. Hyman, Marilyn Albert, Ronald Killiany
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Donalyn Scheuner, Christopher B. Eckman, M. Jensen, X.H. Song, Martin Citron, Nobuhiro Suzuki, Thomas D. Bird, John Hardy, M. Hutton, Walter A. Kukull, Eric B. Larson, Ephrat Levy‐Lahad, Matti Viitanen, Elaine R. Peskind, Parvoneh Poorkaj, Gerald D. Schellenberg, Rudolph E. Tanzi, Wilma Wasco, Lars Lannfelt, Dennis J. Selkoe, Samuel Younkin
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)
Franz X. Vollenweider, Klaus L. Leenders, C Scharfetter, Angelo Antonini, R. P. Maguire, Jack Missimer, Jules Angst
Changes in cortical grey matter density associated with long-standing retinal visual field defects
Christine C. Boucard, Aditya Tri Hernowo, R. P. Maguire, Nomdo M. Jansonius, Jos B. T. M. Roerdink, J. M. M. Hooymans, Frans W. Cornelissen
How much of the research on UCB Pharma (Belgium) is open access?
ScholarIQopen access share
25%OPEN ACCESS